Skip to main content
. 2020 Aug 6;4(5):950–957. doi: 10.1002/jgh3.12396

Table 2.

Physician survey questions

Question Options
What is your gender

  1. Male

  2. Female
What is your age?

  1. 18–24

  2. 25–34

  3. 35–44

  4. 45–54

  5. 55–64

  6. 65+
What is your speciality?

  1. Gastroenterology

  2. Infectious diseases
What is the nature of the majority of your practice?

  1. Advanced trainee

  2. Staff specialist

  3. Private practice physician

  4. Visiting medical officer

  5. Predominantly medical research
Are you aware of the existence of an FMT service in South Australia?

  1. Yes

  2. No
Have you ever referred a patient with CDI for FMT?

  1. Yes

  2. No
If the above answer was yes:

  • How many patients?

  • In how many has the treatment been successful?

  • Could you envisage using the service again in the future?
Have you seen any new diseases develop in your patients following FMT?

  1. No

  2. Yes (please specify)
In you patients who have received FMT for CDI and who have other medical comorbidities, have you noticed any improvement or deterioration in these conditions following FMT?

  1. Improvement (please specify)

  2. Deterioration (please specify)

  3. No change
For which of the following patients with C. difficile in an outpatient setting would you consider FMT? (may select more than one answer)

  1. Prior to antibiotic therapy

  2. Immediately following first treatment course of antibiotics

  3. Following first recurrence (post antibiotic therapy)

  4. Following second recurrence (post antibiotic therapy)

  5. Following three of more recurrences (post antibiotic therapy)
For which of the following patients hospitalised with C. difficile would you consider FMT? (may select more than one answer)

  1. Prior to antibiotic therapy

  2. Following antibiotic therapy for first episode of CDI

  3. Following first recurrence (post antibiotic therapy)

  4. Following second recurrence (post antibiotic therapy)

    Following three of more recurrences (post antibiotic therapy)
For which of the following patients with C difficile would you consider FMT? (may select more than one answer)

  1. Following a severe episode requiring supportive care (HDU or ICU)

  2. Patient not responding to antibiotics

  3. Other (please specify)
Do you believe most of your patients with recurrent or refractor CDI would consider FMT?

  1. Yes

  2. No
If above answer was no—what do you think would be their main reason for not considering FMT?

  1. Aesthetic reasons (i.e. “gross” factor)?

  2. Infection risk

  3. Other transmissible disease risk
Are you concerned regarding potential alteration in the recipient's microbiome?

  1. No

  2. Yes (please explain)
Are you concerned about disease transmission risk?

  1. Yes

  2. No
If above answer was yes, what are your main concerns? (may select more than one answer)

  1. Infection

  2. Metabolic risk (i.e. obesity, insulin resistance)

  3. Autoimmune disease

  4. Other (please specify)
Do you believe these risks outweigh the potential benefits?

  1. Yes

  2. No
How do you believe FMT should be delivered?

  1. Via colonoscopy

  2. Via endoscopy

  3. Naso‐jejunal tube

  4. Enemas
Who do you believe would be an ideal donor?

  1. Spouse

  2. Sibling

  3. Friend or unrelated contact

  4. Donor anonymous to the recipient
Do you think a third party (i.e. Medicare, private insurance or state government) should subsidise the costs to patients for recurrent or refractory FMT?

  1. Yes

  2. No
There is a current debate about the regulation of FMT. In your opinion, should processed donor faeces for FMT be classified as:

  1. Bodily tissue donation

  2. Therapeutic drug

CDI, Clostridioides difficile infection; FMT, fecal microbiota transplantation; HDU, high dependency unit; ICU, intensive care unit.